Potential Gene Therapy for Familial ALS to Enter Preclinical Testing, Voyager Says – ALS News Today
ALS News Today |
Potential Gene Therapy for Familial ALS to Enter Preclinical Testing, Voyager Says
ALS News Today Preclinical testing will soon begin in VY-SOD101, a compound seen as a potential treatment for a certain gene mutation found in people with familial amyotrophic lateral sclerosis (ALS). Its developer, Voyager Therapeutics, hopes to follow this work, … |
